Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Reversible Pulmonary Artery Banding as Simplified Management of End-stage Dilated Left Ventriculopathy in Early Life

NCT02652676 is registered in ClinicalTrials.gov with Loma Linda University as lead sponsor.

NCT NCT02652676
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02652676 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Reversible Pulmonary Artery Banding as Simplified Management of End-stage Dilated Left Ventriculopathy in Early Life
Lead sponsor
Loma Linda University
Phase
Not applicable
Overall status
Terminated
Start date
January 31, 2016
Completion date
May 7, 2021
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute on chronic systolic congestive heart failure